Genevoyager
PrivateLast Round
Series A
Sep 12, 2023
Total Funding Raised
$32.77M
Company Overview
Genevoyager operates in Healthcare & Life Sciences and is based in Wuhan. Its latest recorded funding round was a Series A round in September 2023.
Genevoyager is a biotechnology company that provides one-stop Contract Research, Development, and Manufacturing Organization (CRO/CDMO) services for gene therapy products, specializing in large-scale viral vector preparation and delivery technologies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genevoyager Comparables
Compare Genevoyager with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ascend | 83% | |
| uBriGene Biosciences | 82% | |
| PackGene Biotech | 82% |
For institutional investors. Book with your work email.
Genevoyager Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 12, 2023 | ||||
| Series A | Aug 1, 2023 | ||||
| Pre Seed | Jun 1, 2022 |
For institutional investors. Book with your work email.
Genevoyager Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hongxin Capital | Series A |
| SDIC Venture Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2022
$5.2M raised in Pre Seed round.
For institutional investors. Book with your work email.
Genevoyager Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Genevoyager's valuation, stock price, and market status.
Is Genevoyager a public or private company?
Genevoyager is a private company.
What is the current stock price of Genevoyager?
Genevoyager is a private company, so its shares have no public market price. Caplight tracks Genevoyager's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Genevoyager worth (valuation)?
Valuation information for Genevoyager is not publicly available.
Can I buy Genevoyager stock?
Genevoyager shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Genevoyager's last funding round?
Genevoyager's most recent funding round was Series A on September 12, 2023.
Who are the main investors in Genevoyager?
Key investors in Genevoyager include Hongxin Capital, SDIC Venture Capital.
Will Genevoyager IPO soon?
No public IPO plans have been announced for Genevoyager.
How can I track Genevoyager secondary market activity?
Caplight tracks bids, offers, and trades in Genevoyager's shares on secondary markets.